A Multicenter, Add-On Randomized Controlled Trial of Low-Dose<scp>d</scp>-Serine for Negative and Cognitive Symptoms of Schizophrenia
2012 · The Journal of Clinical Psychiatry · 103 citations
https://doi.org/10.4088/jcp.11m07031
N
Nomi Werbeloff
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
2.9K
Citations
27
h-index
44
i10-index
Nomi Werbeloff is an academic researcher from Bar-Ilan University. The author has contributed to research in topics: Schizophrenia research and treatment & Mental Health Treatment and Access & Suicide and Self-Harm Studies. The author has an h-index of 27, co-authored 88 publications.
ORCID: 0000-0002-5485-615XPapers by this author
worksInitial depression severity and response to antidepressants <i>v.</i> placebo: patient-level data analysis from 34 randomised controlled trials
2016 · The British Journal of Psychiatry · 58 citations
https://doi.org/10.1192/bjp.bp.115.173906
Dementia severity at death: a register-based cohort study
2018 · BMC Psychiatry · 23 citations
https://doi.org/10.1186/s12888-018-1930-5
Individual and area-level risk factors for suicidal ideation and attempt in people with severe depression
2016 · Journal of Affective Disorders · 22 citations
https://doi.org/10.1016/j.jad.2016.08.015
Determinants of antidepressant response: Implications for practice and future clinical trials
2018 · Journal of Affective Disorders · 8 citations
https://doi.org/10.1016/j.jad.2018.06.039
Mental health medication and service utilisation before, during and after war: a nested case–control study of exposed and non-exposed general population, ‘at risk’, and severely mentally ill cohorts
2015 · Epidemiology and Psychiatric Sciences · 2 citations
https://doi.org/10.1017/s2045796015000013
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat